Jennifer J Gao

14PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCancer cell biologyMolecular targetsObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 09, 2026
Project 5 in 5: Paving the Way for Increasing Pragmatism in Clinical Oncology Trials.

Steven Clark Cunningham, Kelly Norsworthy, Jennifer J Gao

|Aug 11, 2025
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Stage II and III High-Risk Early Breast Cancer Treatment Setting.

Jennifer J Gao, Tatiana M Prowell, Haley Gittleman

|Oct 08, 2024
FDA Approval Summary: Capecitabine Labeling Update under Project Renewal.

Sundeep Agrawal, Clara Lee, William F Pierce

|Jun 10, 2024
Reflections and Roadmaps: Career Development beyond the FDA-AACR Oncology Educational Fellowship.

Timil Patel, Chris Chen, Samer Al Hadidi

|Aug 18, 2023
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.

Jennifer J Gao, Christy L Osgood, Zhou Feng

|Jun 29, 2023
Advancing Therapies for Asian Americans, Native Hawaiians, and Other Pacific Islanders With Cancer: OCE's Project ASIATICA.

Jennifer J Gao, Richard Pazdur, Tamy Kim

Pageof 3

Frequent Collaborators

6 joint publications

Richard Pazdur

5 joint publications

Tatiana M Prowell

4 joint publications

Laleh Amiri-Kordestani

3 joint publications

Shenghui Tang